{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T08:36:39Z","timestamp":1792917399223,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017357","name":"Science and Technology Projects of Fujian Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013795","name":"Fujian Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Fujian Provincial Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.bcp.2026.118555","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:21:55Z","timestamp":1792509715000},"page":"118555","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P3","title":["Apatinib attenuates CRKII-Mediated angiogenesis: Possible implications for metastasis prevention from small extracellular vesicle proteomics"],"prefix":"10.1016","volume":"254","author":[{"given":"Shiqin","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunjiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.118555_b0005","doi-asserted-by":"crossref","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians 2024;74:229-63.","DOI":"10.3322\/caac.21834"},{"key":"10.1016\/j.bcp.2026.118555_b0010","doi-asserted-by":"crossref","unstructured":"Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA: a cancer journal for clinicians 2016;66:115-32.","DOI":"10.3322\/caac.21338"},{"key":"10.1016\/j.bcp.2026.118555_b0015","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000331643","article-title":"Triple-negative breast cancer: clinical and histological correlations","volume":"6","author":"Elsawaf","year":"2011","journal-title":"Breast Care"},{"key":"10.1016\/j.bcp.2026.118555_b0020","doi-asserted-by":"crossref","first-page":"167","DOI":"10.7150\/jca.10944","article-title":"Comparison of clinicopathological features and prognosis in triple-negative and non-triple negative breast cancer","volume":"7","author":"Qiu","year":"2016","journal-title":"J. Cancer"},{"key":"10.1016\/j.bcp.2026.118555_b0025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.bcp.2026.118555_b0030","article-title":"Emerging therapeutic drugs in metastatic triple-negative breast cancer","volume":"15","author":"Cipriano","year":"2021","journal-title":"Breast Cancer: Basic and Clinical Research"},{"key":"10.1016\/j.bcp.2026.118555_b0035","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-071674","article-title":"Advances in systemic therapies for triple negative breast cancer","volume":"381","author":"Leon-Ferre","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.bcp.2026.118555_b0040","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.bcp.2011.12.007","article-title":"Apatinib (YN968D1) enhances the efficacy of conventional chemotherapeutical drugs in side population cells and ABCB1-overexpressing leukemia cells","volume":"83","author":"Tong","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118555_b0045","doi-asserted-by":"crossref","first-page":"7981","DOI":"10.1158\/0008-5472.CAN-10-0111","article-title":"Apatinib (YN968D1) reverses multidrug resistance by inhibiting the efflux function of multiple ATP-binding cassette transporters","volume":"70","author":"Mi","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.118555_b0050","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/ijc.28829","article-title":"Multicenter phase II study of apatinib, a novel VEGFR inhibitor in heavily pretreated patients with metastatic triple\u2010negative breast cancer","volume":"135","author":"Hu","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bcp.2026.118555_b0055","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12885-023-11790-6","article-title":"A real-world study of the effectiveness and safety of apatinib-based regimens in metastatic triple-negative breast cancer","volume":"24","author":"Huang","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bcp.2026.118555_b0060","first-page":"3482","article-title":"Two species of human CRK cDNA encode proteins with distinct biological activities","volume":"12","author":"Matsuda","year":"1992","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bcp.2026.118555_b0065","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41420-024-02146-5","article-title":"The role of cancer-associated fibroblasts and exosomal miRNAs-mediated intercellular communication in the tumor microenvironment and the biology of carcinogenesis: a systematic review","volume":"10","author":"Nedaeinia","year":"2024","journal-title":"Cell Death Discovery"},{"key":"10.1016\/j.bcp.2026.118555_b0070","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3390\/cells10040739","article-title":"Crk and CrkL as therapeutic targets for cancer treatment","volume":"10","author":"Park","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2026.118555_b0075","first-page":"1661","article-title":"Exosome-mediated cell-cell communication in tumor progression","volume":"8","author":"Wan","year":"2018","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.bcp.2026.118555_b0080","doi-asserted-by":"crossref","first-page":"12122","DOI":"10.1038\/s41598-025-95232-2","article-title":"Distinct proteomic profiles of plasma-derived extracellular vesicles in healthy, benign, and triple-negative breast cancer: candidate biomarkers for liquid biopsy","volume":"15","author":"Tamarindo","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2026.118555_b0085","doi-asserted-by":"crossref","first-page":"6045","DOI":"10.1021\/acs.jproteome.5c00553","article-title":"Comprehensive Proteomic Profiling of Triple-negative Breast Cancer-Derived Small Extracellular Vesicles unveiled PXDN and GGT5 as Novel Protein Markers Implicated in Oncogenic Signaling Networks","volume":"24","author":"Khraibah","year":"2025","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bcp.2026.118555_b0090","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00018-024-05403-z","article-title":"Comparative profiling of whole-cell and exosome samples reveals protein signatures that stratify breast cancer subtypes","volume":"81","author":"Andreu","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bcp.2026.118555_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2026.117734","article-title":"Nab-paclitaxel inhibits angiogenesis via the CYR61\/integrin \u03b1(v)\u03b2(3) Axis: Exosomal proteomics insights into breast cancer chemoprevention","volume":"509","author":"Zhang","year":"2026","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118555_b0100","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.3389\/fphar.2019.01296","article-title":"RU486 Metabolite Inhibits CCN1\/Cyr61 Secretion by MDA-MB-231-Endothelial Adhesion","volume":"10","author":"Yu","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118555_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.05.007","article-title":"Tumour microenvironment changes after osimertinib treatment resistance in non-small cell lung cancer","volume":"189","author":"Han","year":"2023","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bcp.2026.118555_b0110","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.imr.2019.04.010","article-title":"Therapeutic effect of Cnidium officinale Makino extract on ovariectomized hind-limb ischemic mice","volume":"8","author":"Yang","year":"2019","journal-title":"Integr Med Res"},{"key":"10.1016\/j.bcp.2026.118555_b0115","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41467-022-35431-x","article-title":"Neoadjuvant therapy with immune checkpoint blockade, antiangiogenesis, and chemotherapy for locally advanced gastric cancer","volume":"14","author":"Li","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.118555_b0120","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s12282-020-01055-6","article-title":"The apatinib inhibits breast cancer cell line MDA-MB-231 in vitro by inducing apoptosis, cell cycle arrest, and regulating nuclear factor-\u03baB (NF-\u03baB) and mitogen-activated protein kinase (MAPK) signaling pathways","volume":"27","author":"Maroufi","year":"2020","journal-title":"Breast Cancer"},{"key":"10.1016\/j.bcp.2026.118555_b0125","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s12935-021-02026-3","article-title":"Exosomes from cervical cancer cells facilitate pro-angiogenic endothelial reconditioning through transfer of Hedgehog-GLI signaling components","volume":"21","author":"Bhat","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bcp.2026.118555_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2022.105516","article-title":"Exosome proteomics study of the effects of traditional cigarettes and electronic cigarettes on human bronchial epithelial cells","volume":"86","author":"Wang","year":"2023","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.bcp.2026.118555_b0135","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1093\/jnci\/84.24.1875","article-title":"Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma","volume":"84","author":"Weidner","year":"1992","journal-title":"J. Natl Cancer Inst."},{"key":"10.1016\/j.bcp.2026.118555_b0140","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12865-022-00514-3","article-title":"Blockade of exosome generation by GW4869 inhibits the education of M2 macrophages in prostate cancer","volume":"23","author":"Peng","year":"2022","journal-title":"BMC Immunol."},{"key":"10.1016\/j.bcp.2026.118555_b0145","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.canlet.2019.06.012","article-title":"Tumor-derived extracellular vesicles in breast cancer: from bench to bedside","volume":"460","author":"Wang","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bcp.2026.118555_b0150","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.2174\/1871520621666210412103849","article-title":"Apatinib Inhibits Stem Properties and Malignant Biological Behaviors of Breast Cancer Stem Cells by Blocking Wnt\/\u03b2-catenin Signal Pathway through Downregulating LncRNA ROR","volume":"22","author":"Jiang","year":"2022","journal-title":"Anticancer Agents Med Chem."},{"key":"10.1016\/j.bcp.2026.118555_b0155","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.21037\/atm-21-805","article-title":"Apatinib enhances the anti-tumor effect of paclitaxel via the PI3K\/p65\/Bcl-xl pathway in triple-negative breast cancer","volume":"9","author":"Chen","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.bcp.2026.118555_b0160","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2147\/CMAR.S291029","article-title":"Giant Fungated locally Advanced Breast Carcinoma Responded to Hypofractionated Radiotherapy combined with Apatinib: a Case Report and Literature Review","volume":"13","author":"Liu","year":"2021","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.bcp.2026.118555_b0165","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-026-03188-7","article-title":"Apatinib inhibits synovial sarcoma progression and angiogenesis via VEGFR2-mediated AKT\/FOXO3A and ERK1\/2\/FOXM1 signaling pathways","volume":"12","author":"Liu","year":"2026","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.bcp.2026.118555_b0170","doi-asserted-by":"crossref","first-page":"6075","DOI":"10.2147\/DDDT.S97235","article-title":"Apatinib for molecular targeted therapy in tumor","volume":"9","author":"Zhang","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.bcp.2026.118555_b0175","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1091\/mbc.E19-05-0302","article-title":"The Crk adapter protein is essential for Drosophila embryogenesis, where it regulates multiple actin-dependent morphogenic events","volume":"30","author":"Spracklen","year":"2019","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bcp.2026.118555_b0180","doi-asserted-by":"crossref","first-page":"104552","DOI":"10.18632\/oncotarget.21053","article-title":"Multicenter phase II study of apatinib treatment for metastatic gastric cancer after failure of second-line chemotherapy","volume":"8","author":"Ruan","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2026.118555_b0185","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1242\/jcs.00632","article-title":"Tyrosine phosphorylation of the CrkII adaptor protein modulates cell migration","volume":"116","author":"Takino","year":"2003","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bcp.2026.118555_b0190","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1200\/JCO.2015.63.5995","article-title":"Randomized, Double-blind, Placebo-Controlled phase III Trial of Apatinib in patients with Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction","volume":"34","author":"Li","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bcp.2026.118555_b0195","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00228-023-03579-0","article-title":"Factors influencing methotrexate pharmacokinetics highlight the need for individualized dose adjustment: a systematic review","volume":"80","author":"Yang","year":"2024","journal-title":"Eur. J. Clin. Pharmacol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226008981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226008981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T08:09:09Z","timestamp":1792915749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226008981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":39,"alternative-id":["S0006295226008981"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118555","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apatinib attenuates CRKII-Mediated angiogenesis: Possible implications for metastasis prevention from small extracellular vesicle proteomics","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118555","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118555"}}